• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/14

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

14 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)

Blastomyces dermatitidis

-North America (Ohio and Mississippi River Valleys) ,Africa, SW Asia


-Soil, woody plants, decaying matter


-Inhalation of conidia, inoculation with soil, or dog bite

-Geographic distribution


-Ecological Niche


-Route of Infection

Blastomyces dermatitidis Clinical Syndromes

-Severity dependent on extent of exposure and immune status


-Symptoms in <50% exposed


-Pulmonary disease or extrapulmonary disseminated disease

-Severity/Symptoms


-Incubation Period


-Attack Rate


-Clinical Illness

Pulmonary Blastomycosis

Asymptomatic or present as a mild flu-like illness (severe cases resemble bacterial pneumonia)

Blastomyces dermatitidis Diagnosis

-Microscopic detection of fungus in tissue (confirmed by culture)


-Broad-based budding yeast in tissue


-Serologic Assays not useful, must do molecular assay

Coccidioides immitis/posadasii

-Southwestern US, Mexico, Central/South America


-soil and dust (nitrogenous bat/rodent droppings)


-inhalation of arthroconidia

-Geographic distribution


-Ecological Niche


-Route of Infection

Coccidioides immitis/posadasii Clinical Syndromes

-inhalation of only a few spores can produce primary coccidiomycosis


- fever, cough, headache, rash, muscle aches, joint pain


-skin rash, chronic pneumonia, meningitis, bone and joint infection


-1 to 3 weeks


-30-60% of patients have asymptomatic pulmonary disease


-can be pulmonary or extrapulmonary disseminated disease

-Severity/Symptoms


-Incubation Period


-Attack Rate


-Clinical Illness

Coccidioides immitis/posadasii Diagnosis

-microscopic detection of fungus in tissue


-present as spherules containing endospores


-serologic testing for initial screening and confirmation


-molecular assay

Risk Factors for Disseminated Disease

-infants and elderly


-male (9:1)


-fillipino>black>native american>hispanic>asian


-late pregnancy and post partum


-negative skin test


-chemotherapy, steroids, HIV

-age


-sex


-genetics


-pregnancy


-skin test


-depressed cell-mediated immunity

Histoplasma capsulatum

-North America (Ohio and Mississippi River Valleys), Mexico, Central/South America


-Soil with high nitrogen content


-Inhalation of microconidia

-Geographic distribution


-Ecological Niche


-Route of Infection

Histoplasma capsulatum Clinical Syndromes

-Severity dependent on extent of exposure and immune status


-4 to 18 days


-Symptoms (similar to pneumonia) occur in 10% of infected individuals


-Can cause acute pulmonary histoplasmosis

-Severity/Symptoms


-Incubation Period


-Attack Rate


-Clinical Illness

Histoplasma capsulatum Diagnosis

-Microscopic detection of fungus in tissue


-Appears as small, oval narrow-based budding yeast (intracellular in macrophages)


-Serologic testing (urine or blood) most useful for diagnosis/prognosis


-Molecular assay

Talaromyces (Penicillium) marneffei

-Southcentral, Southeast, East Asia


-Soil isolated from bamboo rats


-Inhalation of spores, traumatic implantation, enteric spread after eating bamboo rat

-Geographic distribution


-Ecological Niche


-Route of Infection

Talaromyces (Penicillium) marneffei Clinical Syndromes

-disseminated infection (skin, soft tissue, viscera)


-Occurs primarily in HIV infected persons in Thailand/Southern China


-Resembles histoplasmosis, cryptococcosis, and tuberculosis

-Severity/Symptoms


-Clinical Illness

Talaromyces (Penicillium) marneffei Diagnosis

-Microscopic detection of fungus in tissues


-Appears as elliptical fission yeast that are intracellular


-Serologic testing under development


-Molecular assay